SMTL ID : 7kza.1

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.69 Å

Oligo State

hetero-1-1-mer

Ligands

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 4 residues within 4Å: Chain A: E.46, W.47 Chain B: T.97, F.98 Ligand excluded by PLIP CL.5: 3 residues within 4Å: Chain B: P.59, S.60, R.61 Ligand excluded by PLIP

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 11 residues within 4Å: Chain A: F.172, P.173, V.175, S.183, L.184, S.185 Chain B: Q.160, S.162, S.176, S.177, T.178 6 PLIP interactions: 3 interactions with chain A, 3 interactions with chain B Hydrogen bonds: A:F.172, A:S.183, A:S.185, B:Q.160, B:S.162, B:T.178 GOL.3: 3 residues within 4Å: Chain A: G.8, T.9, E.10 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.10 GOL.4: 4 residues within 4Å: Chain A: R.38, S.63, F.64, Q.67 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.38, A:R.38 Water bridges: A:D.90 GOL.7: 7 residues within 4Å: Chain B: Q.37, Q.38, K.39, K.42, A.43, K.45 Ligands: GOL.8 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:Q.37, B:K.39, B:A.43 Water bridges: B:A.43 GOL.8: 7 residues within 4Å: Chain B: Q.37, K.45, P.59, F.62, E.81, D.82 Ligands: GOL.7 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:Q.37, B:K.45, B:E.81

1 x NA: SODIUM ION(Non-functional Binders)

NA.6: 1 residues within 4Å: Chain B: G.66 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:S.65, B:G.66

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.9: 8 residues within 4Å: Chain A: Q.39, I.93, Y.95 Chain B: Q.38, K.39, P.40, G.41, K.42 5 PLIP interactions: 4 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:Q.38, B:G.41, B:K.42 Water bridges: B:Q.38, A:Q.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rouet, R. et al., Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies. Mabs

Release Date

2021-02-24

Peptides

Fab fragment heavy chain of anti-CoV2-RBD antibody variant CR3022-B6: A
Fab fragment light chain of anti-CoV2-RBD antibody variant CR3022-B6: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

Fab fragment heavy chain of anti-CoV2-RBD antibody variant CR3022-B6

Fab fragment light chain of anti-CoV2-RBD antibody variant CR3022-B6

Related Entries With Identical Sequence